Invesco Ltd. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 171 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$682,228
-90.7%
40,901
-84.5%
0.00%
-100.0%
Q2 2023$7,303,032
+14.2%
264,411
-4.9%
0.00%0.0%
Q1 2023$6,392,528
+1757.0%
277,936
+780.9%
0.00%
Q4 2022$344,232
+42.2%
31,552
+9.8%
0.00%
Q3 2022$242,000
+3.9%
28,724
-2.6%
0.00%
Q2 2022$233,000
-67.2%
29,503
-1.7%
0.00%
Q1 2022$711,000
+4.9%
30,026
+51.5%
0.00%
Q4 2021$678,000
+70.4%
19,825
-11.7%
0.00%
Q3 2021$398,000
-51.1%
22,452
+23.9%
0.00%
Q2 2021$814,000
+210.7%
18,122
+79.4%
0.00%
Q1 2021$262,000
-92.9%
10,103
-94.7%
0.00%
-100.0%
Q3 2020$3,699,000
-10.6%
189,232
-19.2%
0.00%0.0%
Q2 2020$4,137,000
+590.7%
234,281
+175.9%
0.00%
Q1 2020$599,000
-21.6%
84,930
+33.4%
0.00%
Q3 2019$764,000
-25.7%
63,653
-25.0%
0.00%
Q2 2019$1,028,000
+14.7%
84,849
+19.0%
0.00%
Q1 2019$896,000
+82.9%
71,313
-2.3%
0.00%
Q2 2018$490,000
+1.2%
72,964
+29.6%
0.00%
Q1 2018$484,00056,3080.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders